Form Type: 4

SEC EDGAR Link
Accession Number:0000899243-21-016010
Date:2021-04-13
Issuer: TREVI THERAPEUTICS, INC. (TRVI)
Original Submission Date:

Reporting Person:

GALLETTA CHRISTOPHER
C/O TREVI THERAPEUTICS, INC.
195 CHURCH STREET, 14TH FLOOR NEW HAVEN, CT 06510

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
STOCK OPTION (RIGHT TO BUY) 2.53 2021-04-13 deemed execution date A 25,000 (a) 2031-04-12 common stock 25,000 $2.53 25,000 direct
Footnotes
IDfootnote
f1 this option was granted on april 13, 2021. the 25,000 shares of common stock underlying the option are scheduled to vest as to 25% of the shares on april 12, 2022 and as to the remaining 75% of the shares in equal monthly installments thereafter, through april 12, 2025.
WhaleWisdom Logo

Elevate your investments